Systematic Literature Review: Strategic Business Development and Market Entry Strategies in International Pharmaceutical Trade
DOI:
https://doi.org/10.56830/WRBA03202601Keywords:
International Pharmaceutical Trade, Market Entry Strategies, Regulatory Challenges, Business Development, Digital Transformation, Traditional MedicineAbstract
The international pharmaceutical trade is a fragmented regulatory landscape characterized by innovation-driven growth and digital transformation. This systematic literature review synthesizes academic and industry research on business development models, market entry strategies, regulatory influences, and challenges faced by pharmaceutical companies in their global expansion. It notes that diversified market entry strategies such as foreign direct investment, contractual agreements, and risk-informed strategies are required for successful international expansion, which must adapt to local economic conditions as well as regulatory environments. Key trends identified include a strategic shift toward value-based pricing; increasing reliance on digital sales platforms; and greater integration of ethnopharmacological knowledge into global health frameworks. Regulatory disparities continue to be an important barrier that requires harmonized global processes for drug approval so that patient access can be improved. This review also emphasizes the critical importance of proactive communication with regulatory bodies and flexible, context-specific strategies in navigating complex policy environments. Sustainable global growth will depend on pharmaceutical companies improving their digital capabilities, forming innovative partnerships, and adopting ethical marketing practices. The firms that are strategic communicators and public health partners—not just product providers— are the ones who will do best in this diverse international pharmaceutical market. This analysis was meant to help anyone interested in gaining a competitive edge and fair access to the global pharmaceutical trade.
References
Ahmed, R. R., Vveinhardt, J., & Streimikiene, D. (2018). The direct and indirect impact of pharmaceutical industry in economic expansion and job creation: Evidence from bootstrapping and normal theory methods. Amfiteatru Economic, 20(44), 454-469. DOI: https://doi.org/10.24818/EA/2018/48/454
Al-Jawadi, S., Capasso, P., & Sharma, M. (2018). The road to market implantable drug delivery systems: A review on US FDA’s regulatory framework and quality control requirements. Pharmaceutical Development and Technology, 23(10), 953-963. DOI: https://doi.org/10.1080/10837450.2018.1509348
Amaral, C., Paiva, M., Rodrigues, A. R., Veiga, F., & Bell, V. (2024). Global regulatory challenges for medical devices: Impact on innovation and market access. Applied Sciences, 14(20), 9304. DOI: https://doi.org/10.3390/app14209304
Araja, D., & Sumilo, E. (2020). Pharmaceutical enterprises’ market entry strategies.
Arden, N. S., Fisher, A. C., Tyner, K., Yu, L. X., Lee, S. L., & Kopcha, M. (2021). Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future. International Journal of Pharmaceutics, 602, 120554. DOI: https://doi.org/10.1016/j.ijpharm.2021.120554
Barasa, A. N. (2013). Foreign market entry strategies used by multinational pharmaceutical firms in Kenya. Unpublished MBA project, Nairobi University.
Chandra, P., Kumar, P., Pandey, S. N., Pathak, R., Sharma, H., & Sachan, N. (2024). Overview of the pharmaceutical marketplace. In Pharma Marketing and Pharmacoeconomics, (pp. 1-30). Apple Academic Press. DOI: https://doi.org/10.1201/9781003506362-1
David, B., Wolfender, J. L., & Dias, D. A. (2015). The pharmaceutical industry and natural products: Historical status and new trends. Phytochemistry Reviews, 14, 299-315. DOI: https://doi.org/10.1007/s11101-014-9367-z
Dhar, B., & Joseph, R. K. (2019). The challenges, opportunities and performance of the Indian pharmaceutical industry post-TRIPS. In Innovation, Economic Development, and Intellectual Property in India and China: Comparing Six Economic Sectors, (pp. 299-323). DOI: https://doi.org/10.1007/978-981-13-8102-7_13
Ding, B. (2018). Pharma Industry 4.0: Literature review and research opportunities in sustainable pharmaceutical supply chains. Process Safety and Environmental Protection, 119, 115-130. DOI: https://doi.org/10.1016/j.psep.2018.06.031
Farjadian, F., Ghasemi, A., Gohari, O., Roointan, A., Karimi, M., & Hamblin, M. R. (2019). Nanopharmaceuticals and nanomedicines currently on the market: Challenges and opportunities. Nanomedicine, 14(1), 93-126. DOI: https://doi.org/10.2217/nnm-2018-0120
Goebel, S., Verna, V., Marty, C., & Neadle, S. W. (2023). General overview of global combination product regulatory landscape. In The Combination Products Handbook, (pp. 441-504). DOI: https://doi.org/10.1201/9781003300298-17
Haider, R. (2023). International trade in pharmaceutical products.
Hulstaert, F., Pouppez, C., Primus-de Jong, C., Harkin, K., & Neyt, M. (2023). Gaps in the evidence underpinning high-risk medical devices in Europe at market entry, and potential solutions. Orphanet Journal of Rare Diseases, 18(1), 212. DOI: https://doi.org/10.1186/s13023-023-02801-7
Jalilova, A. (2024). Strategy to increase the share of sales in the pharmaceutical market. Розвитку. DOI: https://doi.org/10.57111/econ/1.2024.53
Köhler, M., Haag, S., Biester, K., Brockhaus, A. C., McGauran, N., Grouven, U., et al. (2015). Information on new drugs at market entry: Retrospective analysis of health technology assessment reports in Germany. BMJ Open, 5(3), e006376. DOI: https://doi.org/10.1136/bmj.h796
Nedelcheva, Y. (2019). Competitiveness in the pharmaceutical industry: A historical overview. Предприемачество, 7(1), 36-47.
Paul, J., & Mas, E. (2020). Toward a 7-P framework for international marketing. Journal of Strategic Marketing, 28(8), 681-701. DOI: https://doi.org/10.1080/0965254X.2019.1569111
Pore, A. V., Bais, S. K., & Shahnawaz, S. M. (2023). Review on pharmaceutical sales and marketing. International Journal of Pharmacy and Herbal Technology, 1(2), 239-248.
Rajput, K., & Pandey, R. K. (2022). Pharmaceutical marketing: A literature review. International Journal of Engineering and Management Research, 12(2), 56-63. DOI: https://doi.org/10.31033/ijemr.12.2.10
Schweitzer, S. O., & Lu, Z. J. (2018). Pharmaceutical Economics and Policy: Perspectives, Promises, and Problems. Oxford University Press. DOI: https://doi.org/10.1093/oso/9780190623784.001.0001
Sharma, A., Kumar, D., & Arora, N. (2023). Analyzing pharmaceutical industry risks under uncertainty for performance improvement: An Indian scenario. Business Process Management Journal, 29(7), 1961-1988. DOI: https://doi.org/10.1108/BPMJ-03-2023-0203
Valverde, J. L. (2014). Latin American pharmaceutical overview. Pharmaceuticals Policy and Law, 16(3-4), 179-206. DOI: https://doi.org/10.3233/PPL-140384
Zeller, C., & Van-Hametner, A. (2018). Reorganizing value chains through foreign direct investment: Austria’s pharmaceutical industry international expansion. Competition & Change, 22(5), 529-557. DOI: https://doi.org/10.1177/1024529418791703
